Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncouplingIrene Dell’Anno(University of Pisa), Stefano Landi(University of Pisa)Cancer Cell InternationalJune 29, 202410.1186/s12935-024-03400-7Cited by 1SaveCiteExport RISWatch citationsRelated PapersDrug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma|Investigational New Drugs|2020|12